fostamatinib and Precursor-B-Cell-Lymphoblastic-Leukemia-Lymphoma

fostamatinib has been researched along with Precursor-B-Cell-Lymphoblastic-Leukemia-Lymphoma* in 1 studies

Other Studies

1 other study(ies) available for fostamatinib and Precursor-B-Cell-Lymphoblastic-Leukemia-Lymphoma

Article	Year
SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric International journal of molecular sciences, 2019, Dec-07, Volume: 20, Issue:24 The presence of the chromosomal rearrangement t(12;21)( Topics: Aminopyridines; Cell Proliferation; Child; Core Binding Factor Alpha 2 Subunit; Cyclohexylamines; Drug Resistance, Neoplasm; Humans; Indazoles; Morpholines; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Oxazines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrazines; Pyridines; Pyrimidines; Syk Kinase; Tumor Cells, Cultured	2019

Article

Year

SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric

International journal of molecular sciences, 2019, Dec-07, Volume: 20, Issue:24

The presence of the chromosomal rearrangement t(12;21)(

Topics: Aminopyridines; Cell Proliferation; Child; Core Binding Factor Alpha 2 Subunit; Cyclohexylamines; Drug Resistance, Neoplasm; Humans; Indazoles; Morpholines; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Oxazines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrazines; Pyridines; Pyrimidines; Syk Kinase; Tumor Cells, Cultured

2019